| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 16.06. | AstraZeneca's Calquence Combo Cuts Progression Risk By 27% In Mantle Cell Lymphoma Trial | 699 | AFX News | LONDON (dpa-AFX) - AstraZeneca Plc. (AZN.L) said that results from the ECHO Phase III trial showed the company's Calquence (acalabrutinib) in combination with bendamustine and rituximab demonstrated... ► Artikel lesen | |
| 16.06. | Roche: Phase III Study Of Columvi Combo Extends Survival In Relapsed Diffuse Large B-Cell Lymphoma | 825 | AFX News | SOUTH SAN FRANCISCO (dpa-AFX) - Roche (RHHBY) announced statistically significant and clinically meaningful results from its Phase III STARGLO study of Columvi (glofitamab) in combination with... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| TESLA | 293 |
| NVIDIA | 253 |
| BAYER | 208 |
| NOVO NORDISK | 202 |
| LILIUM | 182 |
| BYD | 161 |
| EVOTEC | 160 |
| TUI | 142 |
| PALANTIR TECHNOLOGIES | 137 |
| D-WAVE QUANTUM | 121 |
| MICROSTRATEGY | 115 |
| VOLKSWAGEN | 112 |
| RWE | 87 |
| NIO INC ADR | 77 |
| RHEINMETALL | 77 |
| NEL | 74 |
| COMMERZBANK | 73 |
| AMAZON | 71 |
| DEUTSCHE TELEKOM | 71 |
| SUPER MICRO COMPUTER | 70 |
| AIXTRON SE | 69 |
| ATOS | 68 |
| XIAOMI | 68 |
| DEUTSCHE BANK | 67 |
| BASF | 65 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
